Cambridge Investment Research Advisors’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-1,825
| Closed | -$33K | – | 3134 |
|
2022
Q2 | $33K | Sell |
1,825
-30
| -2% | -$542 | ﹤0.01% | 2971 |
|
2022
Q1 | $55K | Sell |
1,855
-175
| -9% | -$5.19K | ﹤0.01% | 3068 |
|
2021
Q4 | $88K | Hold |
2,030
| – | – | ﹤0.01% | 3048 |
|
2021
Q3 | $145K | Sell |
2,030
-300
| -13% | -$21.4K | ﹤0.01% | 2887 |
|
2021
Q2 | $267K | Sell |
2,330
-50
| -2% | -$5.73K | ﹤0.01% | 2559 |
|
2021
Q1 | $247K | Buy |
+2,380
| New | +$247K | ﹤0.01% | 2437 |
|